312-422-1111 [email protected]
  • Stay Updated
  • Become a Member
  • Business Solutions
  • Contact Us
iBIO
  • About
    • Who We Are
    • Leadership
    • Contact
  • PROGRAMS
    • Events Calendar
    • Annual iCON Awards
    • Policy & Advocacy
      • Advocacy Center
      • Advocacy Toolkit
      • Rare Disease
    • Business Solutions
    • LabShare
    • STEMKits
    • StellarGirls
    • BioGENEius Illinois
  • Membership
    • Member Benefits
    • Join iBIO
  • Resources
    • News
    • Member Committees
    • Daily Newsletter
    • IBIO Reports
      • About Illinois
      • Investment Report
      • State Incentives
Select Page
iBIO Opposes “Lowering Drug Prices By Putting America First” Executive Order

iBIO Opposes “Lowering Drug Prices By Putting America First” Executive Order

by John Conrad | Sep 15, 2020 | Policy News

The Illinois Biotechnology Innovation Organization, iBIO, opposes the Trump Administration’s decision to move forward with the flawed concept of a “Most Favored Nation” policy that will dramatically affect most vulnerable seniors and patient communities and...
iBIO Opposes New Drug Pricing Bill from House Democrats Leadership

iBIO Opposes New Drug Pricing Bill from House Democrats Leadership

by John Conrad | Sep 27, 2019 | 2019 Fed Issue, Policy News

On Sept. 19, House Speaker Nancy Pelosi (D-San Francisco) unveiled legislation in the form of the Lower Drug Costs Now Act (H.R. 3) Illinois is home to over 45,000 researchers, doctors, lawyers and business women and men in the biopharma industry who have an...
  • Home
  • About Us
  • Business Solutions
  • Advocacy
  • News
  • Join iBIO
  • Contact Us
  • Facebook
  • X
  • RSS
© 2022 iBIO | All Rights Reserved | Powered by BIRKEY.COM
X